Isofundin (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calcium Chloride Dihydrate, Sod)

Magnesium chloride dissociates into magnesium and chloride ions after infusion. Magnesium participates in over 300 enzymatic reactions, stabilises cell membranes, and helps regulate calcium and potassium channels, while chloride contributes to acid‑base balance and osmotic equilibrium.

The dose of Isofundin is set by the prescribing clinician based on the patient’s current electrolyte levels, fluid status, underlying condition and weight. Dosage is individualized and administered under medical supervision.

Safety data for Isofundin in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical guidance.

To order Isofundin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Isofundin contains a balanced mix of magnesium, potassium, sodium, calcium and chloride, offering a broader electrolyte profile than many single‑ion solutions. This makes it suitable for comprehensive fluid resuscitation, whereas some alternatives may focus only on sodium or potassium replacement.

Isofundin should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Before use, inspect the container for particulate matter and ensure the solution is at room temperature if required by the administration protocol.

Isofundin is administered intravenously as a sterile solution for injection. It is typically infused through a calibrated IV set over a period determined by the prescriber, with infusion rates adjusted according to the patient’s clinical response and electrolyte monitoring.

Serious risks include severe hyperkalemia or hypernatremia that can cause cardiac arrhythmias, anaphylactic reactions to the solution components, and fluid overload leading to pulmonary edema. Continuous monitoring of cardiac rhythm and serum electrolytes is essential.

Isofundin should be avoided in patients with known hypersensitivity to any of its components, in those with uncontrolled hyperkalemia, severe renal failure without appropriate monitoring, or in individuals where rapid fluid expansion could precipitate heart failure.